专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20160108078A1 GLUCOPYRANOSIDE COMPOUND 审中-公开
标题翻译：葡萄糖苷化合物
公开(公告)号：US20160108078A1
公开(公告)日：2016-04-21
申请号：US14981728
申请日：2015-12-28
申请人： MITSUBISHI TANABE PHARMA CORPORATION
发明人： Sumihiro NOMURA , Eiji KAWANISHI , Kiichiro UETA
IPC分类号： C07H19/056 , C07H19/044 , C07H19/04 , C07H19/048 , C07H7/04 , C07H7/06
CPC分类号： C07H19/056 , A61K31/7042 , A61K31/7056 , A61K38/24 , A61K38/28 , A61K45/06 , C07H7/04 , C07H7/06 , C07H19/04 , C07H19/044 , C07H19/048 , A61K2300/00
摘要： A compound of the formula: wherein Ring A and Ring B are: (1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, (2) Ring A is an optionally substituted benzene ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring or an optionally substituted unsaturated fused heterobicyclic ring, or (3) Ring A is an optionally substituted unsaturated fused heterobicyclic ring, and Ring B are independently an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring; X is a carbon atom or a nitrogen atom; Y is —(CH2)n— (n is 1 or 2); or a pharmaceutically acceptable salt thereof, or a prodrug thereof.
摘要翻译：下式的化合物：其中环A和环B是：（1）环A是任选取代的不饱和单环杂环，环B是任选取代的不饱和单环杂环，任选取代的不饱和稠合杂双环，或任选取代的苯环，（2）环A是任选取代的苯环，环B是任选取代的不饱和单环杂环或任选取代的不饱和稠环杂双环，或（3）环A是任选取代的不饱和稠合杂双环环和环B独立地是任选取代的不饱和单环杂环，任选取代的不饱和稠合杂双环或任选取代的苯环; X是碳原子或氮原子; Y为 - （CH 2）n - （n为1或2）; 或其药学上可接受的盐，或其前药。

2. 发明申请

US20180282363A1 GLUCOPYRANOSIDE COMPOUND 审中-公开
公开(公告)号：US20180282363A1
公开(公告)日：2018-10-04
申请号：US16000079
申请日：2018-06-05
申请人： MITSUBISHI TANABE PHARMA CORPORATION
发明人： Sumihiro NOMURA , Eiji KAWANISHI , Kiichiro UETA
IPC分类号： C07H19/056 , C07H19/048 , C07H19/044 , C07H19/04 , C07H7/06 , A61K31/7056 , A61K38/24 , A61K38/28 , A61K45/06 , A61K31/7042 , C07H7/04
摘要： A compound of the formula: wherein Ring A and Ring B are: (1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, (2) Ring A is an optionally substituted benzene ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring or an optionally substituted unsaturated fused heterobicyclic ring, or (3) Ring A is an optionally substituted unsaturated fused heterobicyclic ring, and Ring B are independently an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring; X is a carbon atom or a nitrogen atom; Y is —(CH2)n— (n is 1 or 2); or a pharmaceutically acceptable salt thereof, or a prodrug thereof.

3. 发明申请

US20140296506A1 GLUCOPYRANOSIDE COMPOUND 审中-公开
标题翻译：葡萄糖苷化合物
公开(公告)号：US20140296506A1
公开(公告)日：2014-10-02
申请号：US14299470
申请日：2014-06-09
申请人： MITSUBISHI TANABE PHARMA CORPORATION
发明人： Sumihiro NOMURA , Eiji KAWANISHI , Kiichiro UETA
IPC分类号： C07H7/04
CPC分类号： C07H19/056 , A61K31/7042 , A61K31/7056 , A61K38/24 , A61K38/28 , A61K45/06 , C07H7/04 , C07H7/06 , C07H19/04 , C07H19/044 , C07H19/048 , A61K2300/00
摘要： A compound of the formula: wherein Ring A and Ring B are: (1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, (2) Ring A is an optionally substituted benzene ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring or an optionally substituted unsaturated fused heterobicyclic ring, or (3) Ring A is an optionally substituted unsaturated fused heterobicyclic ring, and Ring B are independently an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring; X is a carbon atom or a nitrogen atom; Y is —(CH2)n— (n is 1 or 2); or a pharmaceutically acceptable salt thereof, or a prodrug thereof.
摘要翻译：下式的化合物：其中环A和环B是：（1）环A是任选取代的不饱和单环杂环，环B是任选取代的不饱和单环杂环，任选取代的不饱和稠合杂双环，或任选取代的苯环，（2）环A是任选取代的苯环，环B是任选取代的不饱和单环杂环或任选取代的不饱和稠环杂双环，或（3）环A是任选取代的不饱和稠合杂双环环和环B独立地是任选取代的不饱和单环杂环，任选取代的不饱和稠合杂双环或任选取代的苯环; X是碳原子或氮原子; Y为 - （CH 2）n - （n为1或2）; 或其药学上可接受的盐，或其前药。

4. 发明申请

US20130289109A1 INHIBITORS OF ALPHA4 MEDIATED CELL ADHESION 审中-公开
公开(公告)号：US20130289109A1
公开(公告)日：2013-10-31
申请号：US13934405
申请日：2013-07-03
申请人： MITSUBISHI TANABE PHARMA CORPORATION
发明人： Takayuki KAWAGUCHI , Sumihiro NOMURA , Mikiko TSUKIMOTO , Toshiyuki KUME , Ila SIRCAR
IPC分类号： C07C233/87
CPC分类号： C07C233/87 , A61K31/198
摘要： The present invention relates to a phenylalanine derivative of Formula (I) wherein X1 is a halogen atom, X2 is a halogen atom, Q is a CH2R— is a carboxyl group which may be esterified; or a pharmaceutically acceptable salt thereof.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式